LB Pre-market | ARM or considers listing only in US, Musk plans to countersue Twitter

News

Halliburton's Q2 revenue in 2022 is $5.07 billion, net profit is $109 million, and EPS is $0.12.

2. Johnson & Johnson: Second-quarter revenue of $24.02 billion, net profit of $4.814 billion, EPS of $1.8, adjusted EPS of $2.59, estimated at $2.55. Downgraded its adjusted EPS forecast for the fiscal year to $10-10.1, from $10.15-10.35.

3. Hasbro's second-quarter net revenue was $1.34 billion, and the market estimate was $1.37 billion. Adjusted earnings per share for the second quarter were $1.15, compared with the market estimate of $0.93. Earnings per share were $1.02 in the second quarter, compared with a loss of $0.17 per share in the same period a year earlier.

4. The Russian Federal Antimonopoly Service (fas) ruled that Apple violated the Antimonopoly Act. The amount of turnover-based fines to be imposed on US tech giant Apple will be determined during the investigation.

5. According to the European Union draft document: The European Union will blacklist the Russian zinc and copper giant UMMC (Ural Mining and Metals Company).

6. Semiconductor industry insiders revealed that the industry market is weak, and Intel, Mywell Technology Group and Qualcomm are preparing to implement price increases to deal with market conditions. Intel is rumored to adjust the quotation of all product lines against the trend on October 2; Mywell Technology is rumored to increase by 7-8% on August 1; Qualcomm is rumored to increase by 4%.

Novartis 2022 Q2 revenue of $12.8 billion, net profit of $1.7 billion, EPS of $0.77.

8. According to foreign media reports, SoftBank has suspended plans to list its chip design company ARM in London and may consider listing only in the United States.

9. [US media: Musk plans to countersue Twitter to get rid of the deal] On July 18, local time, according to the New York Post, citing people familiar with the matter, Tesla CEO Musk plans to countersue Twitter in the next few days to cancel the $44 billion acquisition of Twitter. According to reports, people familiar with the matter said the purpose of the counterclaim was to push a Delaware court judge to give Musk's lawyers more time and power to gather information about fake accounts on Twitter. Meanwhile, a protracted legal battle is expected to weigh on Twitter's stock, giving Musk more leverage to renegotiate the price of the Twitter acquisition.

10 , IBM 2022 Q2 revenue 15.54 billion US dollars, net profit 1.392 billion US dollars, EPS 1.53 US dollars.

11. [China's May U.S. Treasury holdings fall below $1 trillion] China held $981 billion in U.S. Treasuries in May, up from 1.003 trillion in April. Japan held $1.213 trillion in U.S. Treasuries in May and 1.219 trillion in April.

12. Apple plans to slow hiring and spending in some divisions next year in response to a potential recession, according to people familiar with the matter. The decision was made because of greater caution in times of uncertainty, although it was not company-wide policy, the sources said.

Movement

Nasdaq futures rose 1%, S & P 500 futures rose nearly 1% and Dow futures rose 0.77%.

Tesla, Netflix rose 1.5%, Microsoft, Google, Amazon, Meta rose nearly 1%.

Alibaba rose 0.55%, Pinduoduo, NetEase rose nearly 1%, shell fell more than 1%.

Boeing rose more than 1%, Johnson & Johnson rose 0.3% and Halliburton rose more than 1%.

Occidental rose 0.4 percent in premarket trading after Berkshire Hathaway increased its stake by nearly 20 percent.

iQIYI rose more than 6% after announcing a partnership with Douyin on content licensing.

Novartis rose 3%, with Q2 net sales up 5% year over year, reaffirming the group's guidance for fiscal 2022.

IBM fell 6%, Q2 net profit of $1.392 billion was less than expected, and the gross profit margin for the full year is expected to fall to 53.4% from 55.2% in the same period last year.

Bilibili rose more than 1%. It is reported that Bilibili has recently undergone organizational restructuring, involving multiple core business departments and six business leaders, and will fully accelerate commercialization.